Solara Active Pharma Sciences Limited

BSE:541540 Stock Report

Market Cap: ₹31.7b

Solara Active Pharma Sciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Poorvank Purohit

Chief executive officer

₹39.8m

Total compensation

CEO salary percentage72.9%
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure1.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Poorvank Purohit's remuneration changed compared to Solara Active Pharma Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-₹5b

Jun 30 2024n/an/a

-₹6b

Mar 31 2024₹40m₹29m

-₹6b

Dec 31 2023n/an/a

-₹3b

Sep 30 2023n/an/a

-₹325m

Jun 30 2023n/an/a

-₹253m

Mar 31 2023₹5mn/a

-₹222m

Compensation vs Market: Poorvank's total compensation ($USD466.81K) is above average for companies of similar size in the Indian market ($USD268.22K).

Compensation vs Earnings: Poorvank's compensation has increased whilst the company is unprofitable.

CEO

Poorvank Purohit (45 yo)

1.8yrs

Tenure

₹39,800,000

Compensation

Mr. Poorvank Purohit serves as Chief Executive Officer of Solara Active Pharma Sciences Limited since February 03, 2023 and serves as its Director & Managing Director since July 2023. He started his career...

Leadership Team

NamePositionTenureCompensationOwnership
Poorvank Purohit
MD, CEO & Director1.8yrs₹39.80mno data
Arun Baskaran
Chief Financial Officerless than a year₹700.00kno data
Mohan Muthunarayanan
COO & Executive Director2.3yrs₹3.80mno data
Suddapalli Krishna
Company Secretary6.8yrs₹4.80mno data
Arun Pillai
Founder & Non-Executive Directorno datano data5.71%
₹ 1.8b
Hero Velladurai
Chief Scientific Officerless than a yearno datano data
V. Moorthy
Chief Quality Officerno datano datano data

1.8yrs

Average Tenure

Experienced Management: 541540's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Poorvank Purohit
MD, CEO & Director1.4yrs₹39.80mno data
Mohan Muthunarayanan
COO & Executive Directorless than a year₹3.80mno data
Arun Pillai
Founder & Non-Executive Director3.3yrsno data5.71%
₹ 1.8b
Manish Gupta
Non-Executive Directorless than a yearno datano data
Kausalya Santhanam
Independent Director6.7yrs₹1.50mno data
Ramakrishnan Rajagopal
Independent Chairman6.7yrs₹1.50m0.010%
₹ 3.3m
Rajendra Srivastava
Independent Director1.1yrs₹200.00kno data
Kartheek Raju
Non-Executive Non-Independent Director3.3yrsno datano data
Rajiv Nabar
Independent Director1.1yrs₹400.00kno data

1.4yrs

Average Tenure

57yo

Average Age

Experienced Board: 541540's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 12:03
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Solara Active Pharma Sciences Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAntique Stockbroking Ltd.
Kameswari V. S. ChavaliFirstCall Research
Rishabh KaleIndsec Securities & Finance Ltd.